Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




ALA Introduces Award at LabAutomation2007 Conference

By Labmedica staff writers
Posted on 14 Dec 2006
The Association for Laboratory Automation (ALA) has introduced the New Product Award (NPA) designation that will highlight the newest and most innovative products to be unveiled at LabAutomation2007, which will be held in Palm Springs (CA, USA), January 27-31, 2007.

"We are extremely excited about this new program and the timing is right,” said ALA Greg Dummer, executive director. More...
"ALA's LabAutomation event has always served as the platform for the companies in this market space to launch new products and services. Last year, there were more than 25 new products launched at LabAutomation.”

More information on eligibility criteria, rules and regulations for the ALA NPA designation, is available at the LabAutomation2007. The panel of judges, which includes working media in attendance, will consider the following four categories in review of the new products at LabAutomation2007: market opportunity--narrow or broad in scope, impact on the field of laboratory automation and technology, extraordinary technical originality, and quality of supporting data.

Lead NPA judge and ALA leader of the marketing advisory group, Jay Smith, said the ALA NPA designation will be conferred upon the top three winning product entries in the competition.

"I believe we will be looking for new products to demonstrate that they have the chance to be widely adopted in the marketplace over the next 10 years, not just this year,” observed Mr. Smith.

The ALA is a worldwide organization representing leaders in all aspects of laboratory automation. ALA seeks to provide a greater understanding of the importance and value of automation technologies in laboratory settings, and to advance science and promote education related to laboratory automation by encouraging the study, advancing the science, and improving the practice of medical and laboratory automation.



Related Links:
LabAutomation2007

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.